There’s a need in secondary prevention for personalized risk estimates to motivate patients and guide care, researchers say.

A scientific statement has been published by the American College of Cardiology regarding inflammation and cardiovascular disease.

Semaglutide reduces cardiovascular events by 23% and direct heart disease death risk by 26% compared to dulaglutide in older ...

Iran: Researchers have found in a new study that bariatric surgery, especially sleeve gastrectomy (SG), significantly ...

Australia: A pooled analysis of the phase 3 BROOKLYN and BROADWAY trials showed that obicetrapib, when added to ...

Specifically, New Amsterdam will use Caristo’s AI-powered CaRi-Heart and CaRi-Plaque technology to evaluate the efficacy of ...

An updated guideline on the management of dyslipidemias has been published by the European Society of Cardiology and European Atherosclerosis Society.

According to the experts, people who would most benefit from an Apo B test are people: who have metabolic syndrome, diabetes ...

Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.

Authors contributed equally to the final manuscript. We conducted an observational retrospective cohort study using national-level reimbursement data from The Health Insurance Institute of Slovenia ...

Background: This study aimed to create a nomogram to predict a double-zero score for obstructive coronary artery disease (CAD) in a hospital-based cohort initially scoring zero. We compared its ...